Your browser doesn't support javascript.
loading
Baclofen Abuse due to Its Hypomanic Effect in Patients with Alcohol Dependence and Comorbid Major Depressive Disorder
Clinical Psychopharmacology and Neuroscience ; : 187-189, 2017.
Artículo en Inglés | WPRIM | ID: wpr-203960
ABSTRACT
Baclofen is a gamma-aminobutyric acid type B receptor agonist used as an anti-craving agent for treatment of alcohol dependence. It has gained popularity in the recent times because it is well tolerated even in patients with hepatic impairments. Herein we are summarizing the latest literature about baclofen induced hypomania and are reporting a case of baclofen abuse because of its mood elevating property in a patient of alcohol dependence with comorbid major depressive disorder. Literature review and case study of a 36-year-old male with alcohol dependence with comorbid major depressive disorder was prescribed with tablet baclofen as an anti-craving agent along with antidepressant medicines. The patients who did not improve with conventional antidepressant therapy started feeling better in terms of his mood symptoms on taking tablet baclofen. Owing to the mood elevating property he started abusing baclofen. Despite its safety profile in hepatic impairment, one must be very cautious in prescribing baclofen because of its mood altering property which may account for its abuse potentiality.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Baclofeno / Trastorno Depresivo Mayor / Alcoholismo / Trastorno Depresivo Resistente al Tratamiento / Ácido gamma-Aminobutírico Límite: Adulto / Humanos / Masculino Idioma: Inglés Revista: Clinical Psychopharmacology and Neuroscience Año: 2017 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Baclofeno / Trastorno Depresivo Mayor / Alcoholismo / Trastorno Depresivo Resistente al Tratamiento / Ácido gamma-Aminobutírico Límite: Adulto / Humanos / Masculino Idioma: Inglés Revista: Clinical Psychopharmacology and Neuroscience Año: 2017 Tipo del documento: Artículo